Sugi Predict

Sugi Predict / Compounds / SCHEMBL82487

SCHEMBL82487

SCHEMBL82487

CCN(C)c1ccc(C(=O)c2ccc(N(C)CC)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 6/20 0.61
▸ ALDH1A1 P00352 4/20 0.61
▸ MAPT P10636 4/20 0.61
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ ADRA2A P08913 1/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ ADRA2C P18825 1/20 0.48
▸ LMNA P02545 3/20 0.44
▸ SRD5A2 P31213 2/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6842262 0.94 HPGD (0.73) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL8633955 0.92 HPGD (0.67) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL6841742 0.92 ALDH1A1 (0.53) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL15722856 0.87 RAB9A (0.53) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL11800833 0.85 ADRA2A (0.47) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL1784560 0.85 ALDH1A1 (0.52) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL8350993 0.85 MAPT (0.54) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL19771378 0.83 ADRA2A (0.47) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL23247969 0.83 ADRA2A (0.46) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL13331926 0.83 ADRA2A (0.55) HPGDALDH1A1MAPTADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 — — US claimed
EP-3200754-B1 COSMETIC PROCESS FOR ATTENUATING WRINKLES OREAL (FR) 2020-06-10 — — EP claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 — — US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 — — EP claimed
US-20180044560-A1 HIGH TEMPERATURE STABLE, LOW OUTGASSING COMPOSITION, PROTECTIVE TAPE COMPRISING SUCH COMPOSITION AND USE OF SUCH TAPE WITH THIN GLASS CORNING INC (US) 2018-02-15 — — US claimed
EP-3200754-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2017-08-09 — — EP claimed
US-20170209360-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2017-07-27 — — US claimed
WO-2016050793-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2016-04-07 — — WO claimed
US-20070232714-A1 Device having low outgassing photo or electron beam curable rubbery polymer material CORNING INCORPORATED 2007-10-04 — — US claimed
EP-1817390-A2 DEVICE COMPRISING LOW OUTGASSING PHOTO OR ELECTRON BEAM CURED RUBBERY POLYMER MATERIAL Corning Incorporated (US) 2007-08-15 — — EP claimed
WO-2006060592-A2 DEVICE COMPRISING LOW OUTGASSING PHOTO OR ELECTRON BEAM CURED RUBBERY POLYMER MATERIAL CORNING INCORPORATED (US) 2006-06-08 — — WO claimed
US-20050152595-A1 Device comprising low outgassing photo or electron beam cured rubbery polymer material CORNING INCORPORATED 2005-07-14 — — US claimed
US-6797841-B2 HAVING PHOTOINITIATION ACTIVITY WITH MINIMAL OR NO ADVERSE HAZARDOUS CHARACTERISTICS ALBEMARLE CORPORATION 2004-09-28 — — US claimed
US-6762323-B2 EXPOSING A FORMUALTION CONTAINING A PIGMENT AND A PHOTOPOLYMERIZABLE COMPOUND HAVING AN ETHYLENICALLY UNSATURATED DOUBLE BOND TO RADIATION IN PRESENCE NON-MUTAGENIC PHOTOINITIATOR ALBEMARLE CORPORATION 2004-07-13 — — US claimed
US-20040092618-A1 Low outgassing photo or electron beam curable rubbery polymer material, preparation thereof and device comprising same CORNING INCORPORATED 2004-05-13 — — US claimed
US-20040054244-A1 Process of quadricyclane production EXCITON, INC. 2004-03-18 — — US claimed
US-20030078313-A1 Aminobenzophenones and photopolymerizable compositions including the same ALBEMARLE CORPORATION 2003-04-24 — — US claimed
US-20030065049-A1 Aminobenzophenones and photopolymerizable compositions including the same ALBEMARLE CORPORATION 2003-04-03 — — US claimed
US-6479706-B1 Aminobenzophenones and photopolymerizable compositions including the same ALBEMARLE CORPORATION 2002-11-12 — — US claimed
US-4175971-A INITIATOR OF BENZANTHRONE OR 1,2-BENANTHRO QUINONE OR DERIVATIVES AND A 4,4*-BIS/DIALKYLAMINO/BENZOPHENONE FUJI PHOTO FILM CO., LTD. (JP) 1979-11-27 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209360-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES CUTA, MC1R, GLA HPGD 1947/4885ALDH1A1 1493/4885MAPT 2782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.